Generics

News

CEO of Novartis' generics unit quits, sparking sale speculat...

Richard Francis is stepping down as CEO of Novartis’ generics and biosimilars division Sandoz at the end of March, sparking further speculation about the unit’s future.

News

EU steps closer to generics and biosimilars manufacturing wa...

A change to European rules on drug manufacturing that could benefit makers of generics and biosimilars is edging closer, after lawmakers agreed draft legislation that tweaks rules on export

News

Mylan launches Advair generic at 70% discount in US

Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug.

News

FDA finally approves Mylan's Advair generic

The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays.

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

Generics firms the 'biggest cartel in US history' - report

US authorities looking into price fixing in the generics industry are now investigating 16 companies and the price of at least 300 drugs, according to a press report.

News